BackTriSalus Life Sciences Overview

TriSalus Life Sciences Receivables

Latest receivables for TLSI: $6.5M.

Get informed when a big investor buys or sells

+ Follow
Receivables
$6.46M
↑ 15.94% YoYΔ $888000.00 vs prior year quarter

Peer average / median

Loading

TriSalus Life Sciences Receivables History

Loading

TriSalus Life Sciences vs. peers: Receivables Comparison

Loading

TriSalus Life Sciences Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

TriSalus Life Sciences (TLSI) FAQ

As of the most recent data (June 2026), TLSI shows a receivables of $6.5M. That compares with $5.6M in the prior-year period — up 15.9% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, TLSI's receivables is now $6.5M (was $5.6M) — a 15.9% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether TriSalus Life Sciences is outperforming or lagging.

Tracking TLSI's receivables over time shows whether TriSalus Life Sciences is scaling, shrinking, or reshaping that part of the business. The current reading is $6.5M That compares with $5.6M in the prior-year period — up 15.9% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this receivables page, Stockcircle has TriSalus Life Sciences's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect receivables (currently $6.5M) with ownership activity and broader fundamentals.